Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK-1R Antagonist for Cytokine Storm in COVID-19
NCT04468646Phase 3Unknown
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aprepitant in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
aprepitant
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04468646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468646.